Expertise in
26
conditions

Dr. Emanual M. Maverakis

Dermatology
Regents Of The Univ Of Ca
2315 Stockton Blvd, 
Sacramento, CA 
Offers Telehealth
Expertise in
26
conditions
Regents Of The Univ Of Ca
2315 Stockton Blvd, 
Sacramento, CA 

Overview

Emanual Maverakis is a Dermatologist in Sacramento, California. Dr. Maverakis is highly rated in 26 conditions, according to our data. His top areas of expertise are Pyoderma Gangrenosum, Pemphigus, Pemphigus Vulgaris, and Psoriasis.

His clinical research consists of co-authoring 215 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Dermatology

Licenses

Dermatology in CA

Hospital Affiliations

University Of California Davis Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Western Health Advantage
  • HMO
  • INSURANCE PLAN
  • MEDICARE DISCOUNT CARD
  • MEDICARE MAPD
View 11 Less Insurance Carriers -

Locations

REGENTS OF THE UNIV OF CA
2315 Stockton Blvd, Sacramento, CA 95817
Other Locations
REGENTS OF THE UNIV OF CA
3301 C St, Suite 800b, Sacramento, CA 95816

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
Enrollment Status: Completed
Publish Date: May 14, 2025
Comparing Immune Responses to Topical Imiquimod
Comparing Immune Responses to Topical Imiquimod
Enrollment Status: Terminated
Publish Date: November 07, 2024
Intervention Type: Drug
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: September 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Parallel-group, Randomized, Placebo-controlled Ascending Dose Phase I Study Protocol for Dietary Supplementation With Bifidobacterium Longum Subsp. Infantis (B. Infantis) in Healthy Breastfed Infants
A Parallel-group, Randomized, Placebo-controlled Ascending Dose Phase I Study Protocol for Dietary Supplementation With Bifidobacterium Longum Subsp. Infantis (B. Infantis) in Healthy Breastfed Infants
Enrollment Status: Withdrawn
Publish Date: November 15, 2019
Intervention Type: Drug
Study Phase: Phase 1
A Randomized Placebo Controlled Split-body Double-blind Phase II Clinical Trial to Investigate the Safety and Efficacy of Clobetasol 0.05% Ointment for the Treatment of Toxic Epidermal Necrolysis (TEN)
A Randomized Placebo Controlled Split-body Double-blind Phase II Clinical Trial to Investigate the Safety and Efficacy of Clobetasol 0.05% Ointment for the Treatment of Toxic Epidermal Necrolysis (TEN)
Enrollment Status: Withdrawn
Publish Date: August 09, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

215 Total Publications

Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation.
Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation.
Journal: JAMA dermatology
Published: June 18, 2025
Similar Doctors
Expertise in
29
conditions
Dr. Emil Tanghetti
Dermatology
Expertise in
29
conditions
Dr. Emil Tanghetti
Dermatology

Office

5601 J St, 
Sacramento, CA 
 (1.4 miles away)
916-454-5922
Languages Spoken:
English
See accepted insurances

Emil Tanghetti is a Dermatologist in Sacramento, California. Dr. Tanghetti is highly rated in 29 conditions, according to our data. His top areas of expertise are Acne, Rosacea, Plaque Psoriasis, and Comedones.

Expertise in
86
conditions
Dr. Raja K. Sivamani
Dermatology
Expertise in
86
conditions
Dr. Raja K. Sivamani
Dermatology

Raja K. Sivamani, MD Private Practice

1495 River Park Dr, Ste 200, 
Sacramento, CA 
 (3.2 miles away)
916-925-7020
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Raja Sivamani is a Dermatologist in Sacramento, California. Dr. Sivamani has been practicing medicine for over 17 years is highly rated in 86 conditions, according to our data. His top areas of expertise are Rosacea, Actinic Keratosis, Atopic Dermatitis, and Acne. Dr. Sivamani is currently accepting new patients.

Expertise in
88
conditions
Dr. Maxwell Fung
Dermatology
Expertise in
88
conditions
Dr. Maxwell Fung
Dermatology

UC Davis Dermatology Clinic

3301 C St Ste 1300, 
Sacramento, CA 
 (1.7 miles away)
916-734-6111
Languages Spoken:
English
See accepted insurances

Maxwell Fung is a Dermatologist in Sacramento, California. Dr. Fung is highly rated in 88 conditions, according to our data. His top areas of expertise are Basal Cell Skin Cancer, Lichen Planus, Muir-Torre Syndrome, Familial Atypical Multiple Mole Melanoma Syndrome, and Liver Embolization.

Frequently Asked Questions about Dr. Emanual M. Maverakis

How do I make an appointment with Dr. Emanual M. Maverakis?

You can book an appointment with Dr. Emanual M. Maverakis by calling their office at 916-734-2011. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Emanual M. Maverakis a top-rated expert for Pyoderma Gangrenosum?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Emanual M. Maverakis is classified as an Elite expert for Pyoderma Gangrenosum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Emanual M. Maverakis specialize in?

While Dr. Emanual M. Maverakis is a Dermatology, they have specific expertise in Pyoderma Gangrenosum, Pemphigus, and Pemphigus Vulgaris. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Emanual M. Maverakis participate in research or clinical trials?

Yes. Dr. Emanual M. Maverakis has published 215 articles and abstracts on conditions like Pyoderma Gangrenosum. You can view a list of Dr. Emanual M. Maverakis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Emanual M. Maverakis accept my insurance?

Dr. Emanual M. Maverakis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 916-734-2011 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Maverakis's expertise for a condition
ConditionClose
View All 19 Advanced Conditions
View All 170 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile